News coverage about Thermo Fisher Scientific (NYSE:TMO) has trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Thermo Fisher Scientific earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave media stories about the medical research company an impact score of 45.9485049082295 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Shares of Thermo Fisher Scientific (NYSE:TMO) traded down $3.15 during trading on Thursday, reaching $188.32. The company had a trading volume of 2,158,719 shares, compared to its average volume of 1,565,293. The firm has a market cap of $76,380.00, a P/E ratio of 20.82, a PEG ratio of 1.74 and a beta of 1.06. Thermo Fisher Scientific has a twelve month low of $139.88 and a twelve month high of $201.20. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.26 and a quick ratio of 0.81.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.24 by $0.07. The business had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The firm’s revenue was up 13.9% compared to the same quarter last year. During the same quarter last year, the business posted $2.03 EPS. equities research analysts predict that Thermo Fisher Scientific will post 9.36 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.32%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is presently 10.19%.

TMO has been the topic of several recent research reports. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 price target on the stock in a research report on Thursday, September 7th. Morgan Stanley restated an “overweight” rating and issued a $220.00 price target on shares of Thermo Fisher Scientific in a research report on Wednesday, September 6th. Cowen restated an “outperform” rating and issued a $220.00 price target (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Sunday, September 10th. Leerink Swann restated a “buy” rating on shares of Thermo Fisher Scientific in a research report on Monday, October 30th. Finally, Deutsche Bank set a $226.00 price target on Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, October 26th. One equities research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. Thermo Fisher Scientific presently has an average rating of “Buy” and a consensus target price of $205.21.

In related news, CEO Marc N. Casper sold 50,000 shares of the firm’s stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total transaction of $9,419,500.00. Following the sale, the chief executive officer now owns 252,577 shares of the company’s stock, valued at approximately $47,582,981.03. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.49% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Thermo Fisher Scientific (TMO) Receives Daily Media Sentiment Score of 0.19” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another site, it was illegally stolen and reposted in violation of United States & international copyright laws. The legal version of this story can be accessed at

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Insider Buying and Selling by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related stocks with our FREE daily email newsletter.